Asajes Ventures
Finance · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3-11-5 Nihonbashi Honcho 2, Tokyo, Tokyo...Website
www.asajes.comRevenue
<$5 MillionIndustry
About Asajes Ventures
Asajes Ventures Org Chart
Is Asajes Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Asajes Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Asajes Ventures had a recent Job posting/layoffs
Earning: See what the market has to say on Asajes Ventures recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Asajes Ventures
Check if Asajes Ventures has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Asajes Ventures launches new products
Check out if Asajes Ventures is spiking on competitors!
Funding: Get notified immidiatlly once Asajes Ventures has new funding data
Recommended Actions
Find VP level buyers at Asajes Ventures
Find 2 more new buyers
Company Profile Activity
Activity Insights
Asajes Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Asajes Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Asajes Ventures.
Asajes Ventures Tech Stack
A closer look at the technologies used by Asajes Ventures
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Asajes Ventures
Asajes Ventures is a late-stage healthcare investment fund based in Japan, specializing in connecting therapeutic innovations from Western countries with the Asian markets. The company focuses on de-risking and expediting access to the complex Asian drug market for small and mid-size biopharmaceutical companies. It offers a two-in-one investment fu... Read More